Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3675107010 | Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3675109013 | Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4527001000052119 | bendroflumetiazid 5 milligram och propranololhydroklorid 160 milligram, depåkapsel | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has manufactured dose form | Prolonged-release oral capsule | true | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Is a | Propranolol-containing product in oral dose form | false | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Is a | Product containing bendroflumethiazide and propranolol (medicinal product) | false | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has precise active ingredient | Bendroflumethiazide (substance) | false | Inferred relationship | Some | 2 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has precise active ingredient | Propranolol hydrochloride | false | Inferred relationship | Some | 1 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | har täljarvärde som visar styrka | 160 (qualifier value) | false | Inferred relationship | Some | 1 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has basis of strength substance (attribute) | Bendroflumethiazide (substance) | false | Inferred relationship | Some | 2 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | har täljarvärde som visar styrka | 5 (qualifier value) | false | Inferred relationship | Some | 2 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has basis of strength substance (attribute) | Propranolol hydrochloride | false | Inferred relationship | Some | 1 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Is a | Bendroflumethiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Is a | Bendroflumethiazide and propranolol only product in oral dose form | true | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has basis of strength substance (attribute) | Bendroflumethiazide (substance) | true | Inferred relationship | Some | 1 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has basis of strength substance (attribute) | Propranolol hydrochloride | true | Inferred relationship | Some | 2 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has precise active ingredient | Propranolol hydrochloride | true | Inferred relationship | Some | 2 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Has precise active ingredient | Bendroflumethiazide (substance) | true | Inferred relationship | Some | 1 | |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Is a | icke selektiv betablockerare | false | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Is a | Product containing alcohol (product) | false | Inferred relationship | Some | ||
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Is a | Nitrogen and/or nitrogen compound-containing product | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets